| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Geng Tian | |
| Dan Wang | |||
| Fang Liu | |||
| Bin Wang | |||
| Dong Yan | |||
| Jia Mi | |||
| Shuping Zhang | |||
| Xizhen Wang | |||
| Qingxian Huang | |||
| P2860 | cites work | Mendelian randomisation and causal inference in observational epidemiology | Q21144649 |
| ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?* | Q22066036 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| The relationship between RAGE gene four common polymorphisms and breast cancer risk in northeastern Han Chinese | Q33573207 | ||
| Usefulness of Mendelian randomization in observational epidemiology | Q33858805 | ||
| RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC | Q34446751 | ||
| RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment | Q34457327 | ||
| Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese | Q34852481 | ||
| RAGE Signaling Significantly Impacts Tumorigenesis and Hepatic Tumor Growth in Murine Models of Colorectal Carcinoma | Q35102969 | ||
| Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies | Q35545467 | ||
| Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach | Q36231579 | ||
| Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials | Q36367265 | ||
| RAGE gene polymorphism and environmental factor in the risk of oral cancer | Q36745763 | ||
| Soluble receptor for advanced glycation end products and risk of liver cancer | Q36816945 | ||
| Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk | Q38282700 | ||
| Circulating cholesteryl ester transfer protein and coronary heart disease: mendelian randomization meta-analysis | Q38308354 | ||
| Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. | Q43096148 | ||
| Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels | Q43248414 | ||
| Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis | Q43742322 | ||
| Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer | Q43757750 | ||
| RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response | Q44032299 | ||
| Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization | Q44389097 | ||
| Genotyping of -374A/T, -429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients. | Q45001439 | ||
| An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization | Q45024905 | ||
| Glyoxalase I Glu111Ala polymorphism in patients with breast cancer. | Q46006352 | ||
| The interaction between RAGE gene polymorphisms and HPV infection in determining the susceptibility of cervical cancer in a Chinese population | Q51297180 | ||
| Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study | Q51607498 | ||
| Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
| Polymorphisms of Receptor for Advanced Glycation end Products and Risk of Epithelial Ovarian Cancer in Chinese Patients | Q53255565 | ||
| Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. | Q54530434 | ||
| Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer | Q57825092 | ||
| RAGE and its ligands in cancer – culprits, biomarkers, or therapeutic targets? | Q57825098 | ||
| Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer | Q57825328 | ||
| C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study | Q59464754 | ||
| The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk | Q61275259 | ||
| Mendelian randomisation: a new spin or real progress? | Q64134143 | ||
| A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer | Q73701841 | ||
| Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma | Q81064798 | ||
| Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer | Q84861434 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 179-191 | |
| P577 | publication date | 2016-02-08 | |
| P1433 | published in | Journal of International Medical Research | Q15758331 |
| P1476 | title | Genetically lowered concentrations of circulating sRAGE might cause an increased risk of cancer: Meta-analysis using Mendelian randomization | |
| P478 | volume | 44 |
| Q90168057 | Association of RAGE rs1800625 Polymorphism and Cancer Risk: A Meta-Analysis of 18 Case-Control Studies |
| Q37627994 | Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case-control study |
| Q64958736 | Mendelian randomization studies of cancer risk: a literature review. |
| Q64250562 | Pathological Implications of Receptor for Advanced Glycation End-Product () Gene Polymorphism |
Search more.